MEG3 and diabetic kidney disease: In addition, MEG3 also plays a key regulatory role in kidney diseases such as ischemic reperfusion-induced AKI (Yang et al., 2018), diabetic nephropathy (Zha et al., 2019), and transplanted kidney injury (Pang et al., 2019).